Outlook Therapeutics, Inc.
OTLK$0.4702−15.60% 1D
$0.161152-week range$2.54
Updated . Prices are snapshots and may be delayed.
Outlook Therapeutics, Inc. price chart
−18.65% over 7D
$0.601
$0.4702
Oct 18
Oct 20
AI Outlook for Outlook Therapeutics, Inc.
Bearish posture- Long-term trend-27.2% vs 200-day average
- Medium-term trend-27.3% vs 50-day average
- Averages50-day above 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Outlook Therapeutics, Inc. performance
1D
−15.6%
7D
−20.3%
30D
−26.3%
90D
−67.8%
1Y
−64.9%
About Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc. is a biotechnology company based in the United States, listed on NASDAQ since 2016 (ticker OTLK).
Outlook Therapeutics, Inc. market data
What is the price of Outlook Therapeutics, Inc. today?
Outlook Therapeutics, Inc. (OTLK) is at $0.4702, −15.60% on the day.
What is the 52-week range of Outlook Therapeutics, Inc.?
Over the past year Outlook Therapeutics, Inc. has traded between $0.1611 and $2.54. It is currently 13% of the way up that range.
Similar stocks
IBRX
Immunitybio Inc
$9.91+2.3%
VSTM
Verastem Inc
$7.71−3.6%
GRML
Greenland Mines Ltd
$6.49−13.6%
TCRT
Alaunos Therapeutics, Inc. Common Stock
$2.07−43.8%
BDRX
Biodexa Pharmaceuticals PLC
$0.4849−2.6%
RXRX
Recursion Pharmaceuticals, Inc.
$3.74+0.5%
MRNA
Moderna, Inc.
$226.30+4.1%
AKBA
Akebia Therapeutics, Inc.
$0.702−6.4%
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.